SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lessened by FineMark National Bank & Trust

FineMark National Bank & Trust decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,911 shares of the exchange traded fund’s stock after selling 200 shares during the quarter. FineMark National Bank & Trust’s holdings in SPDR S&P Biotech ETF were worth $442,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $43,000.

SPDR S&P Biotech ETF Stock Down 2.3 %

SPDR S&P Biotech ETF stock opened at $85.08 on Thursday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The stock has a market cap of $5.52 billion, a P/E ratio of 11.47 and a beta of 0.99. The company’s fifty day simple moving average is $89.52 and its 200-day simple moving average is $94.12.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.